Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG)

P Pfeiffer, C Rose, B Ejlertsen, M Andersson, D Pedersen, H T Mouridsen

Original languageEnglish
JournalActa Oncologica
Volume35 Suppl 5
Pages (from-to)57
ISSN0284-186X
DOIs
Publication statusPublished - 1996
Externally publishedYes

Keywords

  • Antineoplastic Combined Chemotherapy Protocols/administration & dosage
  • Breast Neoplasms/drug therapy
  • Cyclophosphamide/administration & dosage
  • Drug Administration Schedule
  • Epirubicin/administration & dosage
  • Female
  • Fluorouracil/administration & dosage
  • Humans
  • Neoplasm Metastasis
  • Tamoxifen/administration & dosage

Cite this